F.D.A. Approves Weight Loss Drug to Treat Obstructive Sleep Apnea
Zepbound is the first prescription drug approved specifically to treat the common condition. The Food and Drug Administration on Friday approved the weight loss drug Zepbound to treat obstructive sleep apnea. It is the first prescription medication approved to treat the common sleep disorder.
Tirzepatide is approved for moderate-to-severe obstructive sleep apnea (OSA) in adults with ... reductions in breathing disruptions and weight loss with tirzepatide. Nearly half of trial ...
Related GLP-1 weight-loss drugs might help protect kidneys Biden ... FDA approves weight-loss drug Zepbound to treat sleep apnea Dec. 21 (UPI) -- Zepbound, the new GLP-1 weight-loss ...
In addition to treatment of things like sleep apnea, the weight-loss drugs could lead to more joint replacements, said Sara Mallatt, director of healthcare research at market analysis firm ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback